CAS: 147-58-0; 2-Lodohippuric Acid

该化合物是一种有机化合物,具有与2-iodobenzyl组群相联系的甘蓝细胞,其特征是分子结构,包括一个芳香环,由碘原子体替代,形成其独特的化学特性.它一般看起来像白色的白色和非白色的固体,在极地溶剂中可溶解.碘苯并聚体的存在,增强了它的再活动性,使其在各种化学合成应用中有用,特别是在医药化学领域.N-(2-Iodobenzyl)glycine可以参与核细胞替代反应,因为苯并酰胺碳的电极性质,它可能表现出生物活动,可以探索潜在的药物应用.应当参考安全数据,因为碘子分组群可能构成具体的处理和毒性考虑.总的来说,该化合物可以作为有机合成和研究的重要中间体.

结构式图片

相似化合物

495-69-2 13450-77-6 333349-51-2

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号609-67-6 2-碘苯甲酰氯 | CAS号56-40-6 甘氨酸 | CAS号88-67-5 邻碘苯甲酸 | CAS号69238-60-4 N-(methoxycarbo... | CAS号88-67-5 邻碘苯甲酸 | CAS号56-40-6 甘氨酸

合成工艺路线路线简述

    📜2-碘苯甲酸置于氯化亚砜,水,三乙胺,Lithium Hydroxide体系中,用 甲醇,二氯甲烷,甲苯 用作溶剂,化学反应 6.0H,反应生成2-碘马尿酸
    参考文献:碘(III)催化的溴碳环化反应实现无金属合成3,3-二取代的氧吲哚
    标题:碘(III)催化的溴碳环化反应实现无金属合成3,3-二取代的氧吲哚
    摘要:"我"做到了:精心设计了碘(III)介导的溴碳环化反应作为合成羟吲哚的有效工具.该方法适用于各种结构不同的底物,也具有化学敏感性基团,并且可以以区域和立体选择性方式进入杂环(参见方案).获得的吲哚-2-酮可轻松转化为结构复杂的目标化合物,例如生物碱毒扁豆碱.
    Doi:10.1002/chem.201201232

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-2012232225-A1
    优先权日:2009-08-26
    标 题:Synthesis and isolation of dendrimer systems
    发明人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL
    权利人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of dendrimer systems. In particular, the present invention is directed to novel dendrimer conjugates with defined and limited numbers of ligand conjugates and high levels of structural uniformity, methods of synthesizing the same, compositions comprising the conjugates, as well systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, pain therapy, etc.)).

    专利号:US-2008051323-A1
    优先权日:2004-08-21
    标 题 :Chloroquine drug compositions and methods for their synthesis
    发明人:KOSAK KENNETH M
    权利人:KOSAK KENNETH M
    摘要:This invention discloses compositions of chloroquine-coupled active agents, including methods for their preparation. The prior art has shown that chloroquines given as free drug in high enough concentration, enhances the release of various agents from cellular endosomes into the cytoplasm. The purpose of these compositions is to provide a controlled amount of chloroquine at the same site where the active agent is delivered, thereby reducing the overall dosage needed. n The compositions comprise a chloroquine substance coupled to an active agent directly or through a variety of pharmaceutical carrier substances. The carrier substances include polysaccharides, synthetic polymers, proteins, micelles and other substances for carrying and releasing the chloroquine compositions in the body for therapeutic effect. The compositions can also include a biocleavable linkage for carrying and releasing active agents for therapeutic or other medical uses. The invention also discloses carrier compositions that are coupled to targeting molecules for targeting the delivery of chloroquine substances and active agents to their site of action.

    专利号:US-2007060499-A1
    优先权日:2005-09-15
    标 题 :Chloroquine combination drugs and methods for their synthesis
    发明人:KOSAK KENNETH M
    权利人:KOSAK KENNETH M
    摘要:This invention discloses compositions of chloroquine-coupled active agents, including methods for their preparation. The prior art has shown that chloroquines given as free drug in high enough concentration, enhances the release of various agents from cellular endosomes into the cytoplasm. The purpose of these compositions is to provide a controlled amount of chloroquine at the same site where the active agent is delivered, thereby reducing the overall dosage needed. The compositions comprise a chloroquine substance coupled to an active agent directly or through a variety of pharmaceutical carrier substances. The carrier substances include polysaccharides, synthetic polymers, proteins, micelles and other substances for carrying and releasing the chloroquine compositions in the body for therapeutic effect. The compositions can also include a biocleavable linkage for carrying and releasing active agents for therapeutic or other medical uses. The invention also discloses carrier compositions that are coupled to targeting molecules for targeting the delivery of chloroquine substances and active agents to their site of action.

    专利号:US-2007166281-A1
    优先权日:2004-08-21
    标题 :Chloroquine coupled antibodies and other proteins with methods for their synthesis
    发明人:KOSAK KENNETH M
    权利人:KOSAK KENNETH M
    摘要:This invention discloses compositions of chloroquine-coupled active agents such as therapeutic antibodies or insulin, including methods for their preparation. The prior art has shown that chloroquines given as free drug in high enough concentration, enhances the release of various agents from cellular endosomes into the cytoplasm. The purpose of these compositions is to provide a controlled amount of chloroquine at the same site where the drug is delivered, thereby reducing the overall dosage needed. The compositions comprise a chloroquine substance coupled to a drug directly or through a variety of pharmaceutical carrier substances. The carrier substances include polysaccharides, synthetic polymers, proteins, micelles and other substances for carrying and releasing the chloroquine compositions in the body for therapeutic effect. The compositions can also include a biocleavable linkage for carrying and releasing the drug for therapeutic or other medical uses. The invention also discloses carrier compositions that are coupled to targeting molecules for targeting the delivery of chloroquine substances and antibody or insulin to their site of action.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Alessio Imperiale, Et Al. 123I-Hippuran Renal Scintigraphy With Evaluation Of Single-Kidney Clearance For Predicting Renal Scarring After Acute Urinary Tract Infection: Comparison With (99M)Tc-Dmsa Scanning. J Nucl Med. 2003 Nov;44(11):1755-60.
    [参考文献]: Alessio Imperiale, Et Al. Evaluation Of (123)I-Orthoiodohippurate Single Kidney Clearance Rate By Renal Sequential Scintigraphy In A Large Cohort Of Likely Normal Subjects Aged Between 0 And 18 Years. Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1483-90.
    [参考文献]: Gopal Pathuri, Et Al. Renogram Comparison Of P-[参考文献]: Guillermo Lema, Et Al. Renal Function And Cardiopulmonary Bypass In Pediatric Cardiac Surgical Patients. Pediatr Nephrol. 2006 Oct;21(10):1446-51.
    [参考文献]: Hiromichi Akizawa, Et Al. Renal Brush Border Enzyme-Cleavable Linkages For Low Renal Radioactivity Levels Of Radiolabeled Antibody Fragments. Bioconjug Chem. 2013 Feb 20;24(2):291-9.

    合成参考文献


    摘要:Gerasimova NP, Ismailova DB. [Clinical importance of scintiphotography with DTPA-99mTC in hematuria in children]. Vopr Okhr Materin Det. 1980 Feb;25(2):18–21.
    摘要:Yin, Q.; You, S.-L., Science of Synthesis Knowledge Updates, (2014) 2, 463.
    摘要:Andries-Ulmer, A.; Gulder, T., Science of Synthesis: Catalytic Oxidation in Organic Synthesis, (2017) 1, 390.
    摘要:Lariukova EK, Al'bitskaia AA. [X-ray and radiological study of the kidneys in lymphogranulomatosis]. Med Radiol (Mosk). 1980 Mar;25(3):16–21.
    摘要:Xiao, D.; Du, Y., Science of Synthesis: Hypervalent Halogens in Organic Synthesis, (2025) .
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知